Afleveringen
-
In this episode, they discuss:
Building consumer trust in generative AI is essential for its success in health care.Deloitte plays a significant role in the health care sector, serving various stakeholders.A majority of consumers believe generative AI can reduce wait times and costs.Skepticism towards generative AI has increased among consumers over the past year.Distrust in AI tools is linked to concerns about bias and privacy.Health care data is a high-value target for cyber adversaries.Generative AI can enhance the patient-physician relationship if used correctly.Transparency and ethics are crucial in the deployment of generative AI.Healthcare organizations must educate both patients and clinicians about AI.Deloitte assists organizations in navigating the complexities of AI implementation.Learn more about Deloittes research here :
Building and maintaining health care consumersâ trust in generative AI
https://www2.deloitte.com/us/en/insights/industry/health-care/consumer-trust-in-health-care-generative-ai.html
A little about Jen:
Jen Sullivan, Principal, Deloitte & Touche LLP, is a seasoned and innovative cyber strategy leader with 28 years of experience in technology and cybersecurity, with 24 years of deep focus in life sciences and health care. Her technical infrastructure background has expanded throughout her tenure to a range of security areas including cyber strategy, threat detection and response, data protection and privacy, regulatory compliance, and technical resiliency. Jen serves some of the industryâs largest and most complex clients and leads Deloitteâs Cyber Strategy and Transformation practice. Beyond client service, she has held pivotal leadership roles in talent and business transformation and has a deep passion around health equity. Jen serves on Deloitteâs Cyber executive leadership team, is a leader in Women in Cyber and is the Advisory Life Sciences & Health Care Generative AI leader.
-
Introduction:
In todayâs episode, Sandy sits down with Dr. Dipul Patadia, MD, Senior Director, and Industry Advisor at Salesforce. Together, they explore how Salesforce is shaping the future of healthcare through Agentforce, an innovative AI tool designed to streamline healthcare processes and improve customer care.
As AI-powered agents become an everyday part of healthcare, Dr. Patadia addresses common concerns around their implementation for administrative tasks. He also shares insights into how Agentforce ensures smooth operations while maintaining essential safeguards for patient care.
In this episode, they talk about:How Salesforce ensures safe use of AI agents with human oversight in healthcareAutonomous AI agents vs. assistive agents: How Salesforce is revolutionizing digital healthcare supportLeveraging Salesforceâs AI expertise to create the most effective agents for healthcareThe story behind Einstein: how Salesforceâs AI can transform healthcare operationsA Little About Dr. Patadia:Dr. Patadia is a practicing emergency medicine physician. He serves as the Head of Health System Strategy and Innovation at Salesforce where he aids in contextualizing health systemsâ needs with new and existing technology capabilities. Before joining Salesforce, Dr. Patadia came from Ascension and Advocate Health where he served as a Chief Medical Officer, leading clinical initiatives, and operations for two of its high-acuity hospitals. He has been instrumental in facilitating digital transformation, growing specialty service lines, improving quality outcomes, and designing innovative value-based care strategies.
-
Zijn er afleveringen die ontbreken?
-
In this episode, Sandy Vance speaks to Joseph Hernandez, VP of Channel Sales at BluIP, and Vivek Kuppuswamy, Principal Produce Manager at BluIP. They explore how BluIPâs Conversational AI and Virtual Agent solutions revolutionize healthcare workflows by automating patient interactions, streamlining appointment scheduling, and enhancing the patient experience. They also discuss how AI-driven communication reduces administrative burden, improves operational efficiency, and enables healthcare providers to move past organizational tasks and focus on delivering quality care.
Episode Notes
Beginning with a look at the history of automation in healthcare, Joseph and Vivek explain that the concept behind BluIPâs Conversational AI is not new; it fills a similar role to an automated voice menu. However, BluIPâs Conversational AI does not require callers to use specific language to understand their requests. It can also pick up on context and learn from new interactions. This technology helps to address populations who do not use apps like MyChart and want to interact with someone over the phone while streamlining workflows and reducing churn. Additionally, Joseph, Vivek, and Sandy discuss the future of AI at BlueIP and in health care in general.
In this episode, they discuss:
How AI is transforming the patient experienceThe opportunities that conversational AI is creating for healthcare providersThe primary use-cases for BluIPâs Conversational AI in the healthcare spaceHow BlueIP works with organizations to integrate conversational AI to meet their individual needsThe advances in virtual agent technology that solve for patient populations who want to interact over the phoneThe ROI for Conversational AI, which consists of a combination of tangible returns and a less tangible opportunity costHow Conversational AI reduces churn, increases patient satisfaction, and increases staff satisfactionThe future of Conversational AI in healthcare communicationsBluIPâs continued efforts to innovate, including reducing implementation timelines and low-code applicationsA little about Joseph and Vivek:
Joseph Hernandez is a patient satisfaction advocate and technologist who specializes in conversational Artificial Intelligence and optimizing healthcare workflows. With a deep understanding of both digital channel contact centers and healthcare technologies, he designs patient-centered healthcare solutions for national health systems and community health centers. Drawing on his experience and understanding of the relationships between payers, providers, patients, and population health initiatives, Joseph helps customers optimize their current technology and adopt innovative solutions for the evolving healthcare landscape.
Joseph is also an executive member of several healthcare organizations with a charter to close the gap in healthcare disparities and introduce technologies that lead to better patient outcomes; acting as a conduit between healthcare professionals and national healthcare organizations. At BluIP, Joseph is the VP of Channel Sales; matching clients with BluIPâs solutions.
Vivek is a Principal Product Manager at BluIP, and is driving the growth of BluIPâs AI product portfolio. Prior to working at BluIP, Vivek spent 14 years building enterprise-grade SaaS products, with expertise in entertainment, CPG, and high-tech industries. -
About Marisa Cruz:
Dr. Marisa Cruz is the Vice President of Global Digital Medicine at AMGEN, a renowned global biotechnology company. An endocrinologist and internist, she continues to practice medicine at UCSF, bringing a clinical perspective to her work in digital health. Dr. Cruz oversees AMGENâs digital health strategy, focusing on harnessing data and technology to improve patient outcomes and bridge healthcare accessibility gaps.
Things Youâll Learn:
AMGEN is driving innovation in digital health with initiatives like the LATTICE Consortium, aiming to reduce cardiovascular incidents by 50%.AI and machine learning are playing a crucial role in improving clinical trial diversity and accessibility.Emerging digital health trends, including implementation science and patient-centered care, are reshaping the future of healthcare.AMGENâs patient engagement platform, PARC, empowers patients to actively participate in their own healthcare journey.Resources:
Connect with and follow Marisa Cruz on LinkedIn.Follow Amgen on LinkedIn and visit their website.Explore Amgen PARC websiteDiscover the LATTICE Consortium website. -
About Kevin Mahoney:
Kevin B. Mahoney is the Chief Executive Officer of the University of Pennsylvania Health System, a cornerstone of Penn Medicine. Overseeing six hospitals, 13 multispecialty centers, and numerous outpatient facilities across Pennsylvania, Delaware, and New Jersey, he leads efforts to advance patient care, medical education, and research. Since joining Penn Medicine in 1996, Mahoney has held key leadership roles, becoming CEO in 2019. He has spearheaded major initiatives, including the development of the 1.5-million-square-foot Pavilion and the integration of Penn Medicineâs electronic health records system. A champion of health equity, he established a partnership with Wharton to invest in businesses addressing social determinants of health. Recognized among the most influential figures in healthcare, Mahoney holds an MBA and doctorate from Temple University.
Things Youâll Learn:
The healthcare field faces a critical talent shortage due to retiring baby boomers and a smaller subsequent generation demanding innovative solutions. Cultural shifts are crucial to attracting talent to science and medicine, emphasizing the nobility of healthcare professions over purely financial incentives.Healthcare organizations must remain agile and adaptable, embracing new regulations and technological advancements while staying focused on what matters most: patient care.Artificial intelligence is a crucial tool for achieving precision medicine, enabling proactive healthcare interventions based on individual patient profiles.By repairing systems and improving clinical outcomes, healthcare systems can find ways to continue improving the landscape.Resources:
Connect with and follow Kevin Mahoney on LinkedIn.Discover more about Penn Medicineâs University of Pennsylvania Health System on their LinkedIn and website. -
About Sasha Tyndale:
Sasha Tyndale is a seasoned leader in the pharmaceutical industry with over 20 years of experience spanning oncology, immunology, neuroscience, and more. As Director of Diversity and Patient Inclusion at AbbVie, she drives patient-centric strategies and innovative clinical operations. With expertise in precision medicine and personalized healthcare, she collaborates cross-functionally to enhance patient engagement and future-proof organizations. Previously, she held key roles at PAREXEL and Johnson & Johnson, specializing in strategic patient recruitment and clinical innovation. Sasha holds a Masterâs and Bachelorâs degree in English Literature from Rutgers University. Passionate about advancing equitable healthcare, she is committed to transforming research and improving patient outcomes.
Things Youâll Learn:
AbbVie is making clinical trials more inclusive by ensuring they represent diverse populations affected by the diseases being studied.Through programs like ADMIRE, AbbVie is expanding research access by involving underrepresented healthcare providers in clinical research.AbbVie is simplifying participation in clinical trials by making study materials clearer and designing studies that minimize patient burden.Patient voices are essential in humanizing research, providing valuable insights into real-life disease challenges, and encouraging greater participation in clinical trials.AbbVie is taking bold action to challenge traditional research practices, collaborate with community partners, and improve healthcare access and representation.Educating individuals about clinical trials empowers communities to make informed decisions about participation in medical research.Resources:
Connect with and follow Sasha Tyndale on LinkedIn.Discover more about AbbVie on their LinkedIn and website.Sign up for the ADMIRE program here.If you are considering participating in AbbVieâs clinical research program, click here. -
About Dr. Karin Tollefson:
Dr. Karin Tollefson is a highly accomplished pharmaceutical executive with over 30 years of experience dedicated to advancing cancer care. Currently serving as Chief Oncology Medical Officer at Pfizer, she leads the Oncology Global and US Medical Affairs Division. Before joining Pfizer in 2023, Dr. Tollefson held the role of Senior Vice President and Head of Global Medical Affairs at Seagen Inc., where she successfully launched three practice-changing medicines and built a global medical affairs organization. Her extensive career includes significant tenure at Eli Lilly and Company, where she held various leadership roles in clinical operations, development, and medical affairs. Throughout her career, she has contributed to the launch of eight new medicines, impacting patient care across multiple tumor types and therapeutic areas. Dr. Tollefson is an Independent Director on the Board for Verastem Oncology, and has also served on the boards of the American Lung Association and the Leukemia and Lymphoma Society. She is a 2024 Healthcare Businesswomen's Association Luminary Award recipient, and is a strong advocate for women in the oncology field, being a sponsor of both the Oncology Womenâs Network and the Pfizer Butterfly Community at Pfizer. She holds a Doctorate of Pharmacy from the University of Kansas and completed her undergraduate studies at Kansas State University.
Things Youâll Learn:
The incidence of cancer in people under 50 has increased by 79% since 1990, marking a significant and alarming trend that needs immediate attention, especially with colorectal cancer now the leading cause of cancer death in men and second in women younger than 50 years. Western lifestyle factors such as poor diet, obesity, sedentary behavior, and exposure to toxins are likely significant contributors to the rise of early-onset cancers, suggesting that shifts in lifestyle and public health initiatives could impact cancer rates.Younger cancer patients are often diagnosed at later stages due to a lack of preventative care and symptoms being easily dismissed.Increased screening accessibility is crucial for early detection and prevention. This includes molecular testing and colonoscopies, which offer the opportunity to remove precancerous polyps, preventing them from developing into something more serious.The battle against cancer requires collaborative efforts between healthcare providers, academic institutions, industry partners, and advocacy organizations. This is not just one organization's fight; collaborative efforts must continue.Resources:
Follow Dr. Karin Tollefson, Chief Oncology Medical Officer at Pfizer, on LinkedIn.Discover more about Pfizer on their LinkedIn and website.Read more on Pfizer in Oncology here.Patient Resources/Advocacy Links:
Explore This Is Living With Cancerâs Advocacy Supportâs website.Visit the Global Colorectal Cancer Allianceâs website here. (Pfizer was one of their sponsors)Learn more about the transformative work CancerCare is doing.Find CancerCareâs guide on Biomarker Testing here.Read the best practices for Biomarker Testing Coverage here. (Pfizer had input and was a sponsor)Get AONN Biomarker Navigation here. For the Precision Medicine Toolkit, look here.Empower yourself or your patients with essential navigation resourcesâa site co-created with AONN, to find materials on breast, prostate, health equity, geriatric, and more. (Patient navigators can download and share educational tools for enhanced support.)Deepen your understanding of prostate cancer here. -
About Kimbery Powlell:
Kimberly Powell is the Vice President of Healthcare at NVIDIA, overseeing the global healthcare sector. She leads efforts to advance hardware and software platforms for accelerated computing, AI, and visualization, driving innovation in medical imaging, life sciences, drug discovery, and healthcare analytics. Before this role, Kim managed NVIDIAâs higher education and research initiatives, strategic evangelism programs, NVIDIA AI Labs, and the NVIDIA Inception program. Since joining NVIDIA in 2008, she has been instrumental in positioning NVIDIA GPUs as a foundational technology for medical imaging systems.
Things Youâll Learn:
Generative AI is transforming surgical procedures by supporting all phases of the process, including pre-operative patient education, real-time surgical guidance, and automatic post-surgical documentation, resulting in safer and more efficient operations.Privacy and ethical concerns in healthcare AI are being addressed by embedding models directly into medical devices and introducing reasoning layers to ensure safe, responsible, and ethical operation.Ethical safeguards, or "guardrails," are essential for reducing AI-related risks by preventing the system from operating in unsafe or untrustworthy ways.AI should be seen as a "digital human" teammate in healthcare, enhancing staff efficiency and productivity while improving care quality.Evaluating the ROI of AI requires analyzing its ability to reduce costs from rescheduled surgeries and automate tasks, allowing healthcare staff to focus on patients with the greatest need.Resources:
Connect with and follow Kimberly Powell on LinkedIn.Discover more about NVIDIA on their LinkedIn and website. -
About Dr. Brian Anderson:
Dr. Brian Anderson is a leading voice in health AI as CEO and Co-Founder of the Coalition for Health AI (CHAI), guiding the development of national standards for safe and effective AI in healthcare. Formerly Chief Digital Health Physician at MITRE, he spearheaded crucial research initiatives, including advancements in clinical trials and oncology. An internationally recognized expert, Dr. Anderson speaks frequently on digital health, AI assurance, and interoperability. A Harvard Medical School graduate with an MD (honors) and a BA (cum laude), Dr. Anderson trained at Mass General, practiced at Greater Lawrence Family Health Center, and lives in Boston with his family.
Things Youâll Learn:
A significant gap exists in the lack of independent labs to evaluate health AI, as these are already standard practice in other sectors with regulated technologies. The proposed national network of certified labs will fill this gap by providing independent assessments of AI models, promoting trust in their use.AI model cards are crucial for transparency because they detail the training methodologies and ingredients of AI models. This information helps users, such as physicians, make informed decisions about the toolâs appropriateness for their patients.Clinicians need upskilling to critically evaluate AI tools and make informed decisions about their use in patient care.Generative AI applications like ambient scribes have the potential to greatly mitigate physician burnout by streamlining administrative tasks. This can give them more time to focus on their patients and improve their work-life balance.The creation of quality assurance labs will be a critical first step in AI regulation, helping to bridge the gap between rapidly evolving technology and established safety standards.Resources:
Connect with and follow Dr. Brian Anderson on LinkedIn.Discover more about Coalition for Health AI (CHAI) on their LinkedIn and website. -
About Dr. Maria Ryan:
Maria Ryan, DDS, PhD, is the Executive Vice President and Chief Clinical Officer at Colgate-Palmolive Company, where she oversees the Dental and Dermal Clinical teams, as well as the Knowledge Management and Scientific Communications departments. Before joining Colgate-Palmolive, Dr. Ryan was a Professor and Chair of the Department of Oral Biology and Pathology at Stony Brook University, where she focused on teaching, practicing periodontology, and conducting research. She is the former President of the American Association for Dental, Oral, and Craniofacial Research (AADOCR) and has served on various academic and foundation boards. Dr. Ryan has earned several honors, including NIH National Research Service Awards and a Physician Scientist Award. She was also the recipient of the American Dental Associationâs Achievement Award and the Victress Health Award for her contributions to womenâs health research. Dr. Ryan is a renowned speaker and author, frequently appearing in media to highlight the connection between oral and overall health.
Things Youâll Learn:
Oral diseases are a global health crisis affecting 50% of the world's population and significantly impacting overall health.There is a critical disconnect between medical and dental care, leading to neglect of oral health's importance in overall well-being.Untreated oral diseases, like cavities and gum disease, can increase the risk of cardiovascular disease, stroke, diabetes, and adverse pregnancy outcomes.The "Oral Health Quotient" (OQ) aims to educate the public on their oral health knowledge and practices. Many people don't realize that cavities and gum disease are chronic inflammatory diseases that require treatment.Addressing periodontal disease can lead to reductions in medical costs related to conditions such as cardiovascular disease and diabetes.Preventive measures, like proper brushing, flossing, and limiting sugar, are crucial for avoiding most oral diseases.Resources:
Connect with and follow Dr. Maria Ryan on LinkedIn.Discover more about Colgate-Palmolive on LinkedIn and their website. -
About Dr. Carolyn Jasik:
Carolyn is a board-certified physician with a background in health technology startups, multidisciplinary care, education, and research. As Chief Medical Officer at Omada, she uses her diverse expertise to improve user experience and introduce integrated healthcare solutions. Before joining Omada, Carolyn spent 14 years at the University of California as an Associate Professor of Pediatrics and Clinical Instructor at San Francisco General Hospital. She also served as Vice President of Medical Outcomes at Mango Health, a digital health startup. Carolyn earned a Bachelor's in Public Policy from Princeton University, a Medical Degree from the University of Chicago's Pritzker School of Medicine, and completed her research training at the University of California, San Francisco. She is board-certified in clinical informatics, adolescent medicine, and pediatrics. At Omada, Carolyn supports clinical and research teams, contributing to the development of innovative healthcare solutions.
Things Youâll Learn:
GLP-1 medications require comprehensive wraparound support, including lifestyle changes, mental health, and physical therapy, for effective and sustainable outcomes. The speed of weight loss, rather than the GLP-1 itself, is often the primary driver of muscle mass reduction.Many individuals on GLP-1s aim to eventually discontinue the medication, making long-term lifestyle planning a crucial part of the treatment.Stopping GLP-1s abruptly can trigger rebound weight gain due to the body's natural metabolic response.AI's role in healthcare should be focused on enhancing human care delivery, not replacing the crucial empathetic connection.The future of healthcare will include advanced primary care that addresses the gaps between traditional doctor visits.Resources:
Connect with and follow Dr. Carolyn Jasik on LinkedIn.Discover more about Omada Health on LinkedIn and their website. -
About Andrew Adams:
Andrew Adams is the co-founder of Oak HC/FT, established in 2014 to focus exclusively on investing in healthcare and fintech startups. In 2023, the firm was ranked among the top ten venture capital firms globally. With over 25 years of experience, Andrew has been a key investor in numerous high-profile healthcare companies, including One Medical (acquired by Amazon), iHealth Technologies (merged with Connolly), Therapy Brands (acquired by KKR), and PharMEDium Healthcare (acquired by CD&R), among others. He serves on the boards of several healthcare organizations, including August Bioservices, DispatchHealth, and Unified Women's Healthcare. Andrew has been recognized as one of the Top 25 Healthcare Investors of 2024 by GrowthCap. Prior to co-founding Oak HC/FT, he began his career at Alex. Brown & Sons and holds a BA from Princeton University. His extensive track record highlights his deep expertise in healthcare investment and innovation.
Things Youâll Learn:
Identifying and backing the best entrepreneurs with a strong track record is crucial for achieving impactful scale in healthcare.A blend of technology and personalized services is necessary to effectively engage patients and meet their diverse needs.Effective patient engagement involves an omnichannel approach, meeting patients where they are, whether virtually, in person, or at home.Companies should target specific patient populations with tailored tools, services, and a deep understanding of their needs.The future of healthcare investment lies in companies that deliver real value by addressing cost, quality, and the consumer experience across the healthcare continuum.Resources:
Connect with and follow Andrew Adams on LinkedIn.Discover more about OAK HC/FT on LinkedIn and their website. -
About Joyce Tung:
Joyce Tung, Ph.D., is the Vice President of Research at 23andMe, where she has been since 2007. She leads the research team responsible for consumer health and ancestry research, academic and industry collaborations, computational analyses for therapeutics, and the development of new research methods and tools. Prior to her work at 23andMe, Joyce was a postdoctoral fellow at Stanford University, where she focused on the genetics of mouse and human pigmentation. She earned her Ph.D. in Genetics from the University of California, San Francisco, where she was also a National Science Foundation graduate research fellow. Joyce's leadership at 23andMe has been instrumental in advancing genetic research and innovation in both consumer health and scientific development.
Things Youâll Learn:
Current genetic research heavily favors people of European ancestry, hindering the application of findings to other populations.Large-scale genetic studies, driven by consumer participation, are revealing previously unknown health associations.Empowering consumers with their genetic information shifts the power dynamic in healthcare towards individual control.Genetic research findings are not universally applicable, making diverse participation critical for accuracy and benefit.Consumer participation in research provides individuals with a way to fight back against diseases and contribute to future advancements.Resources:
Connect with and follow Joyce Tung on LinkedIn.Discover more about 23andMe on LinkedIn and their website.Read 23andMeâs depression report here.Learn more about 23andMeâs article on sickle cell trait here. -
AI and automation in healthcare isnât just efficient â it can improve patient and worker satisfaction. In this interview, Sandy Vance discusses AI and automation in healthcare with Ted Dinsmore, the Managing Director of SphereGen Technologies. Ted explains that while the concept of AI has recently exploded as it has seen widespread adoption on the consumer side, the technology that it is based on has existed for years and can help automate mundane processes in hospitals. It can also improve worker retention by removing unfulfilling and repetitive work, freeing up time to focus on higher-value aspects of their roles. Sandy and Ted also cover the downsides of waiting to adopt AI and automation technology, which are mostly related to stagnation and a loss of opportunity.
In this episode, they discuss:
Using AI automation to fill staffing shortages and increase job satisfaction by taking over mundane tasksAutomating prior authorization, eligibility, and denial disputes while increasing patient satisfaction through human interactionHelping clients customize their automation and integration to match their workflowUse cases and ROI seen from organizations who adopt SphereGen automationCreating intelligent document processes to extract data from PDFsThe downsides of waiting to adopt AI automation, which mostly relate to a loss of opportunityA little about Dinsmore:
Ted Dinsmore is the President of SphereGen. The software consulting firm drives digital transformation in the healthcare ecosystem by using AI and automation to make systems more efficient and effective. He helps clients in the US and Europe with automation, software development, and extended reality technology.
When Ted founded his first consulting firm, he became invested in supporting Microsoft solutions for large multinational companies. Striving to stay ahead of new technology, Dinsmore embraced artificial intelligence and extended realities with a focus on improving healthcare processes.
Under Dinsmoreâs leadership since its inception, SphereGen has received multiple awards for its services, including the GNHCC Innovation Award and the Most Promising AR/VR Solutions Provider Award in 2023 from CIOReview. SphereGen guides clients throughout the US and Europe as they begin adopting AI, automation, and expanded realities; customizing technology to meet client needs.
-
About Maria Torroella Carney:
Dr. Maria Torroella Carney is a highly respected internist, geriatrician, and palliative care physician with a robust background in public health. She is the Chief of the Division of Geriatric and Palliative Medicine at the Zucker School of Medicine and an Associate Professor of Medicine. She also holds the position of Chief of Geriatric and Palliative Medicine for Northwell Health. As the first geriatrician to serve as a health department commissioner in New York State, Dr. Carney has made significant contributions to the field of longevity promotion and the care of vulnerable populations. Her research focuses on advanced care planning, shared decision-making, elder abuse, and capacity assessment. She has received numerous awards for her outstanding community service and leadership.
Things Youâll Learn:
Hospice is a model of care focused on quality of life, not just end-of-life, and includes comprehensive support services. It's underutilized due to a lack of understanding and difficult decisions required regarding foregoing certain treatments.Patients should be able to explore hospice without feeling obligated to stop other care immediately.Family caregivers are an "invisible workforce" that requires more support, education, and resources. They are integral to the healthcare team yet often overlooked.Elder orphans, those aging without family support, are a growing concern and need early identification and tailored support.Geriatric medicine and palliative care are in their infancy and require more attention and specialists to meet their increasing needs. There's an insufficient number of professionals in these fields.Resources:
Connect with and follow Maria Torroella Carney on LinkedIn.Discover more about Northwell Health on LinkedIn and their website.Buy Maria Torroella Carneyâs The Aging Revolution here. -
About Dr. Richard Milani:
Dr. Milani serves as the Chief Clinical Innovation Officer, at Sutter Health. His background and research focus on population health with a special interest in chronic disease, medical informatics, preventive medicine, and healthcare technology. After receiving his Internal Medicine training at the University of Florida, Dr. Milani completed fellowships in Critical Care Medicine at the University of Florida, Preventive Medicine, and Clinical Epidemiology at Harvard University (Massachusetts General Hospital), and Cardiovascular Diseases at Ochsner Clinic Foundation. He has authored over 500 medical publications, is on the editorial board for several medical journals, and serves as a frequent lecturer for healthcare systems and Fortune 500 companies as well as an advisor to venture capital firms and emerging healthcare technology companies.
Things Youâll Learn:
AI and scribe companies are being used to reduce clinician documentation time, and reduce 'pajama time'.AI models can predict patient deterioration, such as cardiac arrest, and allow for early intervention, reducing cardiac arrests by 44%.AI should act as an assistant, with a human clinician always in the loop for evaluation and decision-making.Technology should point clinicians toward patients most in need, optimizing care and resource allocation.Digital tools that can monitor the activities of daily living unobtrusively are the future of patient care, especially for elderly patients living alone.Resources:
Connect with and follow Dr. Richard Milani on LinkedIn.Discover more about Sutter Health on LinkedIn and visit their website. -
In this conversation, Dr. David Carmouche discusses the critical transition from fee-for-service to value-based care in the healthcare industry, emphasizing the role of AI in enhancing primary care and improving patient outcomes. He highlights the financial pressures on health systems and the importance of aligning incentives to achieve sustainability. The discussion also covers the innovative solutions offered by Lumeris and the transformative potential of AI in automating care processes and improving patient engagement. Finally, Dr. Carmouche addresses the need for regulatory guardrails as AI becomes more integrated into healthcare delivery.
In this episode , they discuss:
The shift from fee-for-service to value-based care is essential for financial sustainability.AI is poised to transform primary care delivery and patient engagement.Healthcare costs have been deemed unsustainable for decades, necessitating change.Aligning incentives is crucial for improving patient outcomes in healthcare.Lumeris has a decade-long history of partnering with health systems for value-based care.AI can automate and standardize care processes, enhancing efficiency.Data availability and interoperability are key to successful value-based care models.Generative AI can proactively engage patients and improve care delivery.Training clinicians to effectively use AI is vital for its successful integration.Regulatory guardrails will be necessary as AI becomes more prevalent in healthcare.A little about Dr David Carmouche:
David Carmouche, MD, is the Executive Vice President & Chief Clinical Transformation Officer at Lumeris. Dr. Carmouche is a visionary leader in transformational healthcare delivery, with a unique blend of provider, payer, retail, and integrated delivery network leadership experience.
Prior to joining Lumeris, Dr. Carmouche served as Walmartâs Senior Vice President of Healthcare Delivery, where he led the fleet of Walmart Health centers, Walmart Health Virtual Care, a value-based care partnership with Optum, and Walmartâs work to address Social Determinants of Health. Dr. Carmouche has also held significant leadership roles with Ochsner Health, the largest nonprofit academic healthcare system in the Gulf South, and Blue Cross Blue Shield of Louisiana, where he introduced the companyâs first value-based care contracts. Earlier in his career, he built and led a multidisciplinary internal medicine and preventive cardiology practice.
Dr. Carmouche attended Tulane University and LSU Medical School in New Orleans. Board-certified in Internal Medicine, he completed his residency at the University of Alabama at Birmingham, where he later served as Chief Resident. He serves as President of the Board of the Consortium for Southeastern Healthcare Quality and on the advisory board at Stellar Health. He has served on the board of the National Association of Accountable Care Organizations.
-
About Chris Moniz: Chris Moniz is a Managing Director at HSBC Holdings. Previously, he was a Managing Director and Market Manager at SVB Financial Group, leading Northwest & Northeast HealthTech & Medical Devices. A contributing author to HSBC Innovation Banking's 1H 2023 Venture Healthcare Report, Chris offers expertise and actionable insights to healthcare companies and investors.
About Kristin Apple: Kristin Apple is President of LINUS, guiding leaders in health, wellness, and life sciences through transformative decisions. With 20+ years of experience advising major healthcare, pharmaceutical, and CPG companies, she's passionate about healthcare innovation. Previously, she led the healthcare vertical at Egg Strategy. Her background includes nearly six years at Eli Lilly, launching blockbuster drugs. Kristin holds an MBA from the University of Colorado and a degree from Indiana University.
Things Youâll Learn:
There is a growing concern among young physicians that patient trust is eroding, coupled with a mirroring lack of trust in patients.Young physicians are eager to incorporate AI into their practices for diagnosis and therapeutic decision-making while maintaining the human connection as an essential aspect of the patient-physician relationship.Technology should be used to enhance patient connection and streamline administrative tasks, not to replace human interaction.The future of healthcare involves a community-centric approach, with care delivered where people are, integrating their support systems.The healthcare industry must embrace and shape inevitable changes rather than be overtaken by them.Resources:
Connect with and follow Chris Moniz on LinkedIn.Discover more about HSBC on LinkedIn and visit their website.Follow and connect with Kristin Apple on LinkedIn.Learn more about LINUS on their LinkedIn and website.Check out the Health 2035 Report here. -
Sandy and Craig discuss how Wellsheet achieves high clinician satisfaction, how it improves over time, and how it has earned the trust of hospitals across the country. Craig Limoli co-founded Wellsheet as a solution to the frustrations he noticed clinicians had with existing technologies, particularly around accessing patient data in a user-friendly format. Wellsheetâs patient summaries are preferred by 94% of clinicians for chart review, reducing chart review time by 50% and length of stay by 16.3%. Sandy and Craig also discuss Wellsheetâs recent partnership with UpToDate, allowing clinicians to access contextually relevant data faster.
In this episode, they discuss:
How Wellsheet contextualizes data to give clinicians the most relevant information to make treatment decisionsWellsheetâs impact on the inpatient side of healthcare, delivering ROI on clinician satisfaction and burnout while increasing productivityHow Wellsheet addresses workflow bottlenecks at hospitalsThe money hospitals are saving by implementing Wellsheetâs AI solution, which mainly comes from reducing the patient length-of-stays The breadth of adoption across healthcare systems that differentiates Wellsheet as an AI solutionDifferent use-cases for Wellsheet throughout healthcare practicesWellsheetâs partnership with UpToDate, allowing for integration and seamless workflowsA little about Craig:
Craig Limoli founded Wellsheet after seeing the frustration that clinicians faced with existing technologies while he worked at IBM in their Watson Health division. He left his MBA program at Wharton to found Wellsheet with a mission to create a better experience for physicians and care teams.
Aligning his solutions with the problems clinicians identified, Craig built Wellsheetâs AI solution to help clinicians access relevant patient information in a contextualized, user-friendly format. In 2017, Craig brought Wellsheet to the market, primarily serving small practices. Since then, Wellsheet's AI solution has been deployed to hundreds of hospitals across some of the largest health systems in the country and has delivered vast improvements in clinician productivity and experience.
-
About Mark Gee:
Mark Gee is the Chief Growth Officer at Medecision, driving the expansion of Aerialâą, a cloud-based healthcare solution that improves health outcomes, reduces costs, and enhances engagement for value-based care organizations. With extensive experience in healthcare leadership, including roles at WellSky, Ciox/Datavant, and ERT, Gee has launched innovative care solutions and spearheaded data-driven strategies to optimize operations. Holding an M.S. in Instructional Design and Lean Systems Management, he excels in disruptive innovation and strategic growth, positioning Medecision as a leader in transforming healthcare delivery and operational efficiencies.
Things Youâll Learn:
Medecision's platform, Ariel, is designed to accept any data format and process it in real time, a crucial factor for unlocking potential use cases and overcoming the limitations of rigid systems. Traditional care management is failing because it focuses on the sickest 20% of patients, overlooking rising-risk individuals. Medecision's core goal is to deliver proactive care and act as a safety net for patients by identifying problems earlier. Many healthcare organizations have rigid data schemas that slow down implementations and limit the use of valuable data. Medecision created hyper-personalized care journeys with micro cohorts that adapt and learn from each individual's conditions. This approach allows the system to surface needs and provide appropriate resources in real time.Resources:
Connect with and follow Mark Gee on LinkedIn.Follow Medecision on LinkedIn and visit their website. - Laat meer zien
